Under the Food and Drug Administration’s update Friday, officials said regulated cat and dog food manufacturers who sell uncooked or unpasteurized products must reanalyze food safety plans to ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name ...
(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...
[2] The Accelerated Approval Program The FDA introduced the Accelerated Approval Program in regulations in 1992, later codified under the Food & Drug Administration Safety Innovations Act of 2012 ...
Red No. 3, made from petroleum, was first approved for food consumption by the FDA in 1907. It's widely used in candy, cereals, cakes, frostings, carbonated drinks and many other products in the ...
The US Food and Drug Administration (FDA) classified the recall as a Class I risk, the highest warning level, indicating a significant risk of serious health consequences or death. While the ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
The Food and Drug Administration has approved Johnson & Johnson's nasal spray Spravato (esketamine) as a standalone treatment for adults with treatment-resistant depression. This landmark decision ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results